Chargement en cours...
Effect of once‐weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c
AIMS: To evaluate the efficacy and safety of dulaglutide 1.5 and 0.75 mg in patients with type 2 diabetes by subgroups of gender, duration of diabetes and baseline glycated haemoglobin (HbA1c) in the dulaglutide clinical development programme (AWARD‐1 to ‐6 and ‐8 clinical trials). METHODS: Change i...
Enregistré dans:
| Publié dans: | Diabetes Obes Metab |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Blackwell Publishing Ltd
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6084353/ https://ncbi.nlm.nih.gov/pubmed/28817231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13086 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|